ZYUS LIFE SCIENCES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.17 CAD | -1.68% |
|
+17.00% | +30.00% |
| 05-07 | ZYUS Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 04-23 | ZYUS Life Sciences Receives US Patent for Pain Management Drug Candidate | MT |
Evolution of the average Target Price on ZYUS Life Sciences Corporation
Price target over the last 5 years
History of analyst recommendation changes
810685e.BpnOjKvwPfj5XBsMYEJXrCdIIfVA_RAID25P3JJAXMw.Nq2c9fujVpyRDVRlNnpu7lMaZsF1ylhpRA1-7sN5EZt__KrEz4hTtKkmTg~29de0146c1d0c6d22dc92fbb0f908cb2
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.19
CAD
Average target price
2.75
CAD
Spread / Average Target
+131.09%
High Price Target
4
CAD
Spread / Highest target
+236.13%
Low Price Target
1.5
CAD
Spread / Lowest Target
+26.05%
Consensus detail
Consensus revision (last 18 months)
Analysts covering ZYUS Life Sciences Corporation
| Stifel GMP |
- Stock Market
- Equities
- ZYUS Stock
- Consensus ZYUS Life Sciences Corporation